How often eyelids are affected in adults with atopic dermatitis
Frequency of Palpebral Involvement in Adult Atopic Dermatitis, in a Cohort of Patients From Lille and Rouen (France) ; a Multicenter Prospective Study
This project will see how often adults with atopic dermatitis have eyelid (palpebral) involvement and will try patch-testing to look for possible allergic causes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 550 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Lille Academic / other |
| Locations | 2 sites (Lille and 1 other locations) |
| Trial ID | NCT04826744 on ClinicalTrials.gov |
What this trial studies
This is an observational study enrolling adults diagnosed with atopic dermatitis using the Hanifin and Rajka criteria to document how frequently the eyelids are involved. Participants will have a standard dermatology consultation and may undergo allergy-focused evaluations such as patch-testing as part of the protocol. The study will also record associated eye conditions (for example conjunctivitis or keratoconus) and collect clinical data to better describe the palpebral presentation. No investigational drugs are given; the aim is to characterize prevalence and possible allergic contributors to eyelid disease in atopic dermatitis.
Who should consider this trial
Good fit: Adults (18+) with atopic dermatitis by revised Hanifin and Rajka criteria who can give oral consent and have valid social insurance are ideal candidates.
Not a fit: People under 18, those who are pregnant or breastfeeding, patients with uncontrolled asthma, or those without social insurance are excluded and would not be eligible to participate or benefit from this observational protocol.
Why it matters
Potential benefit: If successful, the study could help clinicians recognize eyelid involvement earlier and guide more targeted allergy testing and management for affected patients.
How similar studies have performed: Previous publications estimate palpebral involvement at about 20% but prospective allergological (patch-test) studies in this specific patient group are essentially lacking, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Atopic Dermatitis according to the revised Hanifin and Rakja criteria (UK Working Party) * Oral consent * Valid social insurance Exclusion Criteria: * Personal history of uncontrolled asthma * No social insurance * Protective measures * Age under 18 * Pregnancy or breast-feeding
Where this trial is running
Lille and 1 other locations
- Hop Claude Huriez Chu Lille — Lille, France (Recruiting)
- Hopital Charles Nicolle Chu Rouen — Rouen, France (Recruiting)
Study contacts
- Principal investigator: Delphine Staumont-Salle, MD,PhD — University Hospital, Lille
- Study coordinator: Delphine Staumont-Salle, MD,PhD
- Email: delphine.salle@chru-lille.fr
- Phone: 0320445962
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.